Loading Events

« All Events

  • This event has passed.

Please join the FDA Office of Women’s Health, in collaboration with the Center for Drug Evaluation and Research and Center for Tobacco Products, for a conference on Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender. This public meeting will be held on September 27 and 28, 8:30 AM – 4:00 PM, FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room (Rm. 1503-A), Silver Spring, MD 20993.

This two-day scientific conference will begin with keynote speeches by FDA Commissioner Scott Gottlieb and the U.S. Surgeon General, VADM Jerome M. Adams, M.D., M.P.H. Presentations will follow from researchers, clinicians, and policy experts discussing sex and gender influences on substance misuse, abuse, and cessation.

To register to attend this special event, or view the webcast, go to https://go.usa.gov/xUk8P. Everyone much register and space is limited for in-person attendance, so register early.


September 27, 2018
September 28, 2018
Event Category:


FDA Office of Women’s Health


FDA White Oak Campus
10903 New Hampshire Ave, Bldg. 31
Silver Spring, MD 20993 United States
+ Google Map